Research article · 15 Apr 2026
Conference abstractPublished 31 Mar 2016
Palliative care service utilization among end-stage renal disease patients on hemodialysis: A 5-year retrospective analysis
Mayo Clinic, USA
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Integration of palliative medicine into dialysis programs offers opportunities to improve the quality of end-of-life (EOL) care. Hospice Services (HS) are underutilized in the end-stage renal disease population. This retrospective study evaluates the Palliative Care (PC) and HS involvement in Hemodialysis (HD) population. We reviewed medical records of deceased patients who had dialyzed at a single dialysis unit between 2010 and 2015. Timing and frequency of palliative/hospice consults and location of death were analyzed. 114 deaths were reviewed; 58% were men and median age 79. PC and HS were involved in 72% and 8% of the cases respectively. PC has increased from 38% (2010) to 92% (2015). HS also increased from 0% (2010) to 17% (2015). Median timing for PC referral was 91 days prior to death and 16.5 days for HS. 98% of first PC consultations were done in the inpatient setting. There was no difference in location of death between those who received PC versus who didnâÂ?Â?t. However, patients who had PC involved were less likely to receive life sustaining measures (i.e. cardiopulmonary resuscitation, mechanic ventilation or pressors) prior to death (9% vs. 33%; p=<0.001). PC and HS utilization has increased over the past 5 years in this unit. They may help improve the quality care by ensuring that patientsâÂ?Â? care matches their goals as evidenced by fewer patients receiving aggressive treatment in the peri-mortal period. Systematic approach to proactively identify patients with poorer prognoses is necessary to determine goals of care and maximize EOL quality.
Subjects
Nephrology & UrologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Nephrology & Therapeutics.
Brief report · 30 Mar 2026
Renal Fibrosis: Targeting Pathways For New Therapies
Brief report · 30 Mar 2026
SGLT2 Inhibitors: A New Era for Diabetic Kidney Disease
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Nephrology & Therapeutics
- SubjectNephrology & Urology
- BylineArticles whose byline prints “Maria Gonzalez Suarez”
- BylineArticles whose byline prints “Wonngarm Kittanamong Kolchai”
- BylineArticles whose byline prints “Molly Feely”
- BylineArticles whose byline prints “James Gregoire”
